Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation

Colorectal cancer (CRC) is the fifth leading cause of cancer death and the fifth most commonly diagnosed cancer in China. Approximately, 25% of CRC was in the advanced stage as diagnosed, and 40% of patients with CRC progress to metastatic colorectal cancer (mCRC). RAS mutation status is now routine...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ruiqi, Peng, Ke, Yu, Yiyi, Liang, Li, Xu, Xiaojing, Li, Wei, Yu, Shan, Liu, Tianshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831827/
https://www.ncbi.nlm.nih.gov/pubmed/29662888
http://dx.doi.org/10.1155/2018/5920608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831827/
https://www.ncbi.nlm.nih.gov/pubmed/29662888
http://dx.doi.org/10.1155/2018/5920608

Ejemplares similares